Vision-Sciences Announces Peer-Reviewed Publication of Clinical Study Utilizing Its EndoSheath(R) Technology to Diagnose Esophageal Disease
17 mai 2012 16h15 HE
|
Vision-Sciences, Inc.
ORANGEBURG, N.Y., May 17, 2012 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI), a leading provider of unique flexible endoscopic products utilizing its proprietary sterile disposable...
Vision-Sciences Announces Record Revenue of $4.6 Million for Fourth Quarter and $16.7 Million for Full Year Fiscal 2012
15 mai 2012 07h00 HE
|
Vision-Sciences, Inc.
ORANGEBURG, N.Y., May 15, 2012 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI), a leading provider of unique flexible endoscopic products utilizing its proprietary sterile disposable...
Vision-Sciences Announces Release Date of Fourth Quarter and Full Year Fiscal 2012 Results
08 mai 2012 16h15 HE
|
Vision-Sciences, Inc.
ORANGEBURG, N.Y., May 8, 2012 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI), a leading provider of unique flexible endoscopic products utilizing its proprietary sterile disposable...
Vision-Sciences Announces Purchase Agreement for up to $15 Million With Lincoln Park Capital Fund, LLC
27 avr. 2012 16h44 HE
|
Vision-Sciences, Inc.
ORANGEBURG, N.Y., April 27, 2012 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI), a leading provider of unique flexible endoscopic products utilizing its proprietary sterile disposable...
Vision-Sciences, Inc. to Present at Lazard Healthcare Conference on November 16, 2011
10 nov. 2011 16h22 HE
|
Vision-Sciences, Inc.
ORANGEBURG, N.Y., Nov. 10, 2011 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI) today announced that executive management will present at the Lazard Capital Markets Healthcare Conference to be...
Vision-Sciences, Inc. Announces Net Sales Growth of 73% to $4.0 Million for the Second Quarter of Fiscal 2012
07 nov. 2011 16h15 HE
|
Vision-Sciences, Inc.
ORANGEBURG, N.Y., Nov. 7, 2011 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI) today announced financial results for its second quarter and first half of fiscal 2012, ended September 30, 2011....
Vision-Sciences, Inc. Schedules Second Quarter and First Half of Fiscal 2012 Conference Call for November 8, 2011
02 nov. 2011 16h29 HE
|
Vision-Sciences, Inc.
ORANGEBURG, N.Y., Nov. 2, 2011 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc., (Nasdaq:VSCI) will issue financial results for the second quarter and first half of fiscal 2012, ended September 30, 2011,...
Vision-Sciences' Pioneering Technology Featured on The Doctor Oz Show
19 sept. 2011 09h30 HE
|
Vision-Sciences, Inc.
ORANGEBURG, N.Y., Sept. 19, 2011 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI) announced today that its unique, advanced Transnasal EndoSheath® Esophagoscopy system will be featured on...
Vision-Sciences, Inc. Appoints Cynthia F. Ansari Chief Executive Officer
10 août 2011 16h30 HE
|
Vision-Sciences, Inc.
ORANGEBURG, N.Y., Aug. 10, 2011 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc., (Nasdaq:VSCI) announced today that its Board of Directors has named Cynthia F. Ansari as Chief Executive Officer and elected...
Vision-Sciences, Inc. Announces $3.8 Million in Revenue for the First Quarter of Fiscal 2012
10 août 2011 16h30 HE
|
Vision-Sciences, Inc.
ORANGEBURG, N.Y., Aug. 10, 2011 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI) today announced financial results for its first quarter of fiscal 2012, ended June 30, 2011. For the first...